comparemela.com

Latest Breaking News On - Ikena oncology company profile - Page 1 : comparemela.com

Wedbush Lowers Ikena Oncology (NASDAQ:IKNA) to Neutral

Wedbush cut shares of Ikena Oncology (NASDAQ:IKNA – Free Report) from an outperform rating to a neutral rating in a research note issued to investors on Wednesday, Marketbeat Ratings reports. The firm currently has $2.00 price target on the stock, down from their prior price target of $8.00. Wedbush also issued estimates for Ikena Oncology’s […]

United-states
Ikena-oncology-company-profile
Ikena-oncology-inc
Management-co
Sg-americas-securities
Ikena-oncology
Free-report
Marketbeat-ratings
Oncology-trading-down
Get-free-report
Capital-partners

HC Wainwright Cuts Ikena Oncology (NASDAQ:IKNA) Price Target to $4.00

Ikena Oncology (NASDAQ:IKNA – Free Report) had its target price cut by HC Wainwright from $11.00 to $4.00 in a research note published on Wednesday morning, Benzinga reports. They currently have a buy rating on the stock. HC Wainwright also issued estimates for Ikena Oncology’s Q2 2024 earnings at ($0.29) EPS, Q3 2024 earnings at […]

United-states
Ikena-oncology-inc
Sg-americas-securities
Ikena-oncology-company-profile
Barclays-plc
York-mellon-corp
Ikena-oncology
Free-report
Oncology-trading-down
Get-free-report
New-york-mellon-corp

Ikena Oncology (NASDAQ:IKNA) Trading 9.3% Higher

Ikena Oncology, Inc. (NASDAQ:IKNA – Get Free Report)’s stock price traded up 9.3% on Monday . The stock traded as high as $2.03 and last traded at $1.99. 103,653 shares were traded during mid-day trading, a decline of 16% from the average session volume of 123,631 shares. The stock had previously closed at $1.82. Analyst […]

United-states
William-blair
Jpmorgan-chase-co
Charles-schwab-investment-management-inc
Nasdaq
Ikena-oncology-company-profile
Blackrock-inc
Vanguard-group-inc
Ikena-oncology-inc
Ikena-oncology
Get-free-report
Schwab-investment-management

Ikena Oncology (NASDAQ:IKNA) Rating Reiterated by William Blair

William Blair restated their outperform rating on shares of Ikena Oncology (NASDAQ:IKNA – Free Report) in a report published on Thursday morning, RTT News reports. Several other analysts have also weighed in on IKNA. HC Wainwright dropped their price objective on shares of Ikena Oncology from $18.00 to $11.00 and set a buy rating for […]

United-states
William-blair
Blackrock-inc
Vanguard-group-inc
Ikena-oncology-company-profile
Jpmorgan-chase-co
Charles-schwab-investment-management-inc
Ikena-oncology-inc
Ikena-oncology
Free-report
Schwab-investment-management
State-street-corp

Ikena Oncology's (IKNA) Outperform Rating Reaffirmed at William Blair

William Blair reaffirmed their outperform rating on shares of Ikena Oncology (NASDAQ:IKNA – Free Report) in a report issued on Thursday, RTT News reports. Several other analysts have also recently issued reports on the stock. Wedbush initiated coverage on shares of Ikena Oncology in a research note on Thursday, September 21st. They set an outperform […]

United-states
William-blair
Ikena-oncology-inc
Ikena-oncology-company-profile
Artal-group
Citadel-advisors
Blackrock-inc
Ikena-oncology
Free-report
Get-free-report
Ikena-oncology-daily
Nasdaq-ikna

vimarsana © 2020. All Rights Reserved.